Spanish National Research Council | GenomeWeb

Spanish National Research Council

Called CanPathPro, the research consortium aims to combine omics data and systems biology tools into a single commercial platform for testing cancer hypotheses.

NEW YORK (GenomeWeb News) – Some cases of premature ovarian failure and related infertility may be due to mutations affecting proteins involved in meiosis, according to a pair of exome sequencing reports published in the New England Journal of Medicine yesterday.

NEW YORK (GenomeWeb Daily News) – An international team of researchers sequenced the genome and characterized a handful of alleles from a Mesolithic skeleton dating back some 7,000 years.

Qiagen will distribute a new amplification buffer from Sygnis Pharma under a licensing agreement between the companies, Sygnis said today.

German pharmaceutical company Sygnis Pharma said today that it is acquiring X-Pol Biotech, a subsidiary of Spanish biotechnology holding company Genetrix, in a bid to further develop and market X-Pol's DNA sequencing technologies and products, including its DNA polymerase technol

An ethics committee at the Spanish National Research Council is reportedly calling for researchers to retract a paper published last year describing an array-based approach for measuring metabolite levels and enzyme activity.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.